Is the Use of Parasympathomimetics for Treating an Underactive Urinary Bladder Evidence-Based?
Tuesday, 03 April 2007
BJUI Mini Reviews - April 2007 - An underactive urinary bladder (UUB), often occurring after surgery, can lead to urinary retention even in otherwise healthy people.
read more
|
European Urology - The Pattern and Progression of Lower Urinary Tract Symptoms after Transurethral Prostatectomy Compared with Those Seen in the General Population
Monday, 02 April 2007
Volume 51, Issue 4, Pages 1023-1030 (April 2007)
Abstract -
Objectives:
Men undergoing transurethral prostatectomy (TURP) often have some level of residual symptoms after this operation.
read more
|
European Urology - Safety and Effectiveness of Photoselective Vaporization of the Prostate (PVP) in Patients on Ongoing Oral Anticoagulation
Monday, 02 April 2007
Volume 51, Issue 4, Pages 1031-1041 (April 2007)
Abstract -
Objectives:
Ongoing oral anticoagulation (OA) contraindicates transurethral electroresection of the prostate.
read more
|
European Urology - Acetylcholine and Molecular Components of its Synthesis and Release Machinery in the Urothelium
Monday, 02 April 2007
Volume 51, Issue 4, Pages 1042-1053 (April 2007)
1. Introduction
Synthesis and release of acteylcholine (ACh) is not restricted to specialized subsets of neurons but also occurs in a broad variety of non-neuronal cells, in particular in surface epithelia [1], [2].
read more
|
BJUI Mini Reviews - Is the Use of Parasympathomimetics for Treating an Underactive Urinary Bladder Evidence-Based?
Sunday, 01 April 2007
As such drugs can have potentially harmful side-effects, this review systematically sought and assessed reports to determine whether their use is evidence-based.
Login to read more...
|
EAU 2007 - Session on BPH: Intervention Therapy 1
Friday, 30 March 2007
read more
|
SUFU 2007 - Does Current Percpetion Threshold Testing Selectively Measure Different Populations of Afferent?
Monday, 26 March 2007
read more
|
SUFU 2007 - Lower Urinary Tract Symptoms Associated with Obstructive Sleep Apnea Improve after Treatment with Continuous Positive Airway Pressure
Friday, 23 March 2007
read more
|
SUFU 2007 - Up-Regulation of Connexin Gene Expression in Urinary Bladder Smooth Muscle Induced by Mediators of Hypertrophy
Thursday, 22 March 2007
read more
|
SUFU 2007 - The Effect of Sildenafil Citrate on Bladder Outlet Obstruction on a Mouse Model
Wednesday, 21 March 2007
read more
|
SUFU 2007 - Caveolin Gene Expression in Urinary Bladder Smooth Muscle Is Regulated By Angiotensin-II
Tuesday, 20 March 2007
read more
|
SUFU 2007 - The Effect of Anti-Muscarinic Agents on Post-Void Residual Urine Volume (PVR) in High Risk Male Patients with Lower Urinary Tract Symptoms (LUTS)
Friday, 16 March 2007
read more
|
SUFU 2007 - Photoselective Vaporization of the Prostate (PVP) Using the Greenlight High Performance System (HPS) in the Canine Model
Tuesday, 13 March 2007
read more
|
SUFU 2007 - Predictive Factors for Post-Robotic Prostatectomy (RP) Urinary Incontinence (UI) in Men with Pre-Operative Lower Urinary Tract Symptoms (LUTS)- a Pilot Study
Thursday, 08 March 2007
read more
|
The Placebo Effect in the Pharmacologic Treatment of Patients with Lower Urinary Tract Symptoms
Thursday, 01 March 2007
BERKELEY, CA (UroToday.com) - All physicians involved in the treatment of PBS/IC understand that the placebo effect likely plays a major role in treatment, and is important when evaluating drug trials.
read more
|
SUFU 2007 - Primary Bladder Neck Dysfunction: Can We Do Better in Screening for It and Monitoring Its Response to Therapy?
Thursday, 01 March 2007
read more
|
European Urology - Terazosin Modifies the Content of Glycosaminoglycans and the Activity of Matrix Metalloproteinase 2 in the Rat Ventral Prostate
Thursday, 22 February 2007
Volume 51, Issue 2, Pages 447-456 (February 2007)
Abstract -
Objectives:
We have investigated the effects of terazosin on the content of glycosaminoglycans (GAGs), the activity of matrix metalloproteinase 2 (MMP-2) and MMP-9, and the content of tissue inhibitors of MMP (TIMP) in the ventral prostate of Wistar rats.
read more
|
Traditional Foley Drainage Systems—Do They Drain the Bladder?
Monday, 19 February 2007
BERKELEY, CA (UroToday.com) - It is assumed that Foley catheter systems continuously and completely empty the bladder. Beside observations and tubing manipulation that cause a sudden rush of urine flow suggests otherwise.
read more
|
Effect of 1 mg/day Finasteride on Concentrations of Serum Prostate-Specific Antigen in Men with Androgenic Alopecia: A Randomized Controlled Trial
Friday, 16 February 2007
BERKELEY, CA (UroToday.com) - Daily finasteride therapy at the prescribed dose for benign prostatic hyperplasia (5 mg) is known to result in a decrease in serum PSA by 50 percent.
read more
|
European Urology - Voiding Symptom Evaluation: It is Time to Recalibrate
Thursday, 15 February 2007
Volume 51, Issue 2, Pages 302-303 (February 2007) Those of us who care for men (and women) who have voiding symptoms are swept by the conundrum of distinguishing quantity from quality. Over the past 20 yr, various symptoms scores such as the Madsen-Iversen, International Prostate Symptom Score (IPSS), and Danish Prostatic Symptom Score (DAN-PSS-1) have focused on quantifying symptoms.
read more
|
European Urology - Seminal Plasma Cytokines and Chemokines in Prostate Inflammation: Interleukin 8 as a Predictive Biomarker in Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Benign Prostatic Hyperplasia
Wednesday, 14 February 2007
Volume 51, Issue 2, Pages 524-533 (February 2007) Abstract - Objective:This prospective study quantified cytokine and chemokine levels in seminal plasma of patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and benign prostatic hyperplasia (BPH), to evaluate inflammatory mediators as possible surrogate markers for diagnosis and treatment efficacy.
read more
|
European Urology - Impact of LUTS Using Bother Index in DAN-PSS-1 Questionnaire
Friday, 09 February 2007
Volume 51, Issue 2, Pages 473-478 (February 2007) 1. IntroductionA fundamental goal for developing scoring systems for lower urinary tract symptoms (LUTS) has been a need to quantify subjective symptoms of benign prostatic hyperplasia (BPH) and find objective support for the prostatic surgery decision-making.
read more
|
Severe Form of “Enlarged Prostate” Disease Discovered
Wednesday, 07 February 2007
BERKELEY, CA (Newswise) - — Millions of middle-aged and older men experience the symptoms of an enlarged prostate multiple times during the day and night.
read more
|
European Urology - Detection of Escherichia coli 16S RNA and Cytotoxic Necrotizing Factor 1 Gene in Benign Prostate Hyperplasia
Wednesday, 07 February 2007
Volume 51, Issue 2, Pages 457-463 (February 2007) Abstract - Objectives: Inflammation and occasionally necrosis is observed in the prostate tissue from patients with benign prostate hyperplasia (BPH). The etiology of prostatic inflammation/necrosis is unknown, but bacteria may be involved.
read more
|
Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia
Wednesday, 17 January 2007
CORONA, CA (PRESS RELEASE) - Jan. 16 - Statistical Significance Reached on Primary and Secondary Endpoints
read more
|
A Systematic Review of the Reliability of Frequency-Volume Charts in Urological Research and its Implications for the Optimum Chart Duration
Wednesday, 17 January 2007
BJUI - Mini Review - January 2007 To determine how the reliability of frequency volume charts (FVCs) vary with their duration when used to assess patients with lower urinary tract symptoms (LUTS) and whether the duration influences patient compliance.
read more
|
European Urology - The Correlation between Metabolic Syndrome and Prostatic Growth in Patients with Benign Prostatic Hyperplasia
Wednesday, 10 January 2007
Volume 51, Issue 1, Pages 199-206 (January 2007) Abstract - Objectives:To evaluate the relationship between metabolic syndrome and annual prostatic growth rates in benign prostatic hyperplasia (BPH) patients.
read more
|
American Urological Association Names New Director of Guidelines
Wednesday, 03 January 2007
BALTIMORE, January 2007 — The American Urological Association (AUA) has announced that Heddy Hubbard, Ph.D., M.P.H., R.N., F.A.A.N. will be the new Director of Guidelines for the association. Dr. Hubbard joined the AUA on December 28, 2006.
read more
|
European Urology - The Efficacy of Drugs for the Treatment of LUTS/BPH, A Study in 6 European Countries
Monday, 01 January 2007
Volume 51, Issue 1, Pages 207-216 (January 2007) Abstract - Objectives: This paper profiles the usage and effectiveness of various LUTS/BPH drugs in real-life practice.
read more
|
European Urology - The Detrusor Muscle: An Innocent Victim of Bladder Outlet Obstruction
Monday, 01 January 2007
Volume 51, Issue 1, Pages 57-66 (January 2007) Abstract - Objectives: Benign prostatic hyperplasia (BPH) is considered a frequent cause of bladder outlet obstruction (BOO) and lower urinary tract symptoms (LUTS), although the physiopathologic mechanism through which BPH causes LUTS is not clear.
read more
|
BJUI Mini Reviews - A Systematic Review of the Reliability of Frequency-Volume Charts in Urological Research and its Implications for the Optimum Chart Duration
Monday, 01 January 2007
This article reports a systematic review of studies
that assessed the reliability of FVCs, with the
aim of determining the optimum FVC
duration for assessing the voiding behaviour
of patients with LUTS.
Login to read more...
|
European Urology - Unexpected Insights into Pelvic Function Following Phosphodiesterase Manipulation—What's Next for Urology?
Friday, 22 December 2006
Volume 50, Issue 6, Pages 1153-1156 (December 2006) Article Outline: The review article concerning phosphodiesterases (PDEs) submitted by Ückert et al. is both excellent and comprehensive in its evaluation of the PDE isoenzymes and their potential role in various urologic settings [1].
read more
|
European Urology - Update on Phosphodiesterase (PDE) Isoenzymes as Pharmacologic Targets in Urology: Present and Future
Thursday, 21 December 2006
Volume 50, Issue 6, Pages 1194-1207 (December 2006) 1. IntroductionThe cyclic nucleotide monophosphates (cNMPs) cAMP and cGMP are important intracellular regulators of several processes, including smooth muscle motility, electrolyte homeostasis, neuroendocrine signals and retinal phototransduction [1], [2].
read more
|
European Urology - Alfuzosin (10mg) Does Not Affect Blood Pressure in Young Healthy Men
Monday, 18 December 2006
Volume 50, Issue 6, Pages 1292-1298 (December 2006) Abstract - Objectives: Alfuzosin 10mg is a uroselective α1-adrenoceptor antagonist used to treat lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Recent studies have suggested the potential efficacy of alfuzosin in the treatment of distal ureteral stones and prostatitis syndrome, two conditions frequently encountered in young patients.
read more
|
European Urology - Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study
Thursday, 07 December 2006
Volume 50, Issue 6, Pages 1306-1315 (December 2006) Abstract - Objective: Estimate the prevalence of urinary incontinence (UI), overactive bladder (OAB), and other lower urinary tract symptoms (LUTS) among men and women in five countries using the 2002 International Continence Society (ICS) definitions.
read more
|
European Urology - Complications of Transurethral Resection of the Prostate (TURP)—Incidence, Management, and Prevention
Wednesday, 22 November 2006
Volume 50, Issue 5, Pages 969-980 (November 2006) Abstract - Objectives: To update the complications of transurethral resection of the prostate (TURP), including management and prevention based on technological evolution.
read more
|
PSA Testing in Men Who Present with Hematuria
Wednesday, 22 November 2006
BERKELEY, CA (UroToday.com) - Hematuria is a non-specific symptom mandating an evaluation of the upper and lower urinary tract. Hematuria by itself is not considered a standard indication for PSA testing.
read more
|
Testosterone Replacement Therapy Appears Safe for Prostate
Friday, 17 November 2006
BERKELEY, CA (UroToday.com) - Preliminary research suggests that testosterone replacement therapy for men with low testosterone levels appears to have little effect on the prostate gland, contrary to some reports that this therapy may be harmful, according to a study in the November 15 issue of JAMA, a theme issue on men's health.
read more
|
BJUI Mini Reviews - The Enlarged Prostate: a Brief History of its Surgical Treatment
Thursday, 09 November 2006
The enlarged prostate has plagued men since antiquity, or at least when they lived long enough to reach the ‘prostatic’ age.
read more
|
European Urology - Photoselective Vaporization of the Prostate: Subgroup Analysis of Men with Refractory Urinary Retention
Wednesday, 25 October 2006
Volume 50, Issue 5, Pages 1040-1049 (November 2006) Abstract - Objectives: The purpose of this study was to evaluate the feasibility and efficacy of photoselective vaporization of the prostate (PVP) in patients with refractory urinary retention (RUR) secondary to benign prostate hyperplasia (BPH).
read more
|
Proposal Would Name Male Testosterone Decline the “Testosterone Deficiency Syndrome” (TDS)
Thursday, 05 October 2006
BERKELEY, CA (UroToday.com) - Men, as they age, often develop symptoms of increased fatty girth, decreased muscle mass and erectile dysfunction along with other negative bodily changes.
read more
|
European Urology - Anticholinergic Drugs in Patients with Bladder Outlet Obstruction and Lower Urinary Tract Symptoms: Where do we Stand in 2006?
Thursday, 05 October 2006
Volume 50, Issue 4, Pages 653-654 (October 2006) The presence of storage symptoms is extremely common in patients with bladder outlet obstruction (BOO).
read more
|
European Urology - Alpha antagonists—from initial concept to routine clinical practice
Monday, 02 October 2006
Volume 50, Issue 4, Pages 635-642 (October 2006) It is a great honour and a pleasure for me to participate in this celebration of the 50th volume of European Urology by commenting on this landmark review paper by Marco Caine, who was the pioneer of pharmacotherapy for lower urinary tract symptoms (LUTS) suggestive of benign prostatic outlet obstruction (BOO; previously referred to as symptomatic benign prostatic hyperplasia [BPH]), which are so common in ageing men.
read more
|
The Thermo-Expandable Metallic Stent for Managing Benign Prostatic Hyperplasia: a Systematic Review
Friday, 22 September 2006
BERKELEY, CA (UroToday.com) - The surgical management of LUTS or urinary retention secondary to BPH is not without risks, especially in the older patient or those with significant co-morbidities.
read more
|
European Urology - Micronutrients and BPH
Tuesday, 19 September 2006
Volume 50, Issue 3, Pages 413-415 (September 2006) Descriptive epidemiology suggests that the incidence and prevalence of prostatic diseases vary significantly in different areas of the world [1], [2], [3]. Possible reasons for such wide variations have been explored and nutritional factors were found to play a role together with genetic, behavioral, occupational, and environmental ones.
read more
|
European Urology - Characteristics of Patients Presenting with LUTS/BPH in Six European Countries
Tuesday, 19 September 2006
Volume 50, Issue 3, Pages 555-562 (September 2006) Abstract - Objectives: Knowledge of the clinical profile of the population with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) is important for health care management, impacting on manpower requirements, pharmacologic demands and health service costs.
read more
|
European Urology - Holmium Laser Enucleation of the Prostate Versus Open Prostatectomy for Prostates >70g: 24-Month Follow-up
Monday, 18 September 2006
Volume 50, Issue 3, Pages 563-568 (September 2006) 1. Introduction: Open prostatectomy (OP) is the most common surgical approach for benign prostate hyperplasia (BPH) in large prostates in many parts of Europe [1], [2].
read more
|
European Urology - A Randomised Trial Comparing Holmium Laser Enucleation Versus Transurethral Resection in the Treatment of Prostates Larger Than 40Grams: Results at 2 Year
Friday, 15 September 2006
Volume 50, Issue 3, Pages 569-573 (September 2006) 1. Introduction The surgical management of men with large prostates (>40g) that cause bladder outflow obstruction (BOO) secondary to benign prostatic hyperplasia (BPH) is a challenging area.
read more
|
Prostate Issues Fail to Engage Aging European Male
Friday, 15 September 2006
ARNHEM, THE NETHERLANDS (Press Release) - September 2006 - Article on the Occasion of Prostrate Awareness Day - Complacency, shame and undetected symptoms are among the key reasons why middle-aged European males neglect to seek medical help when experiencing prostate ailments.
read more
|
Mayo Clinic Finds What Causes Men Pain in Prostate Biopsy and Best Method to Alleviate It
Friday, 15 September 2006
ROCHESTER, Minn.(Press Release) - September 2006 - Researchers at Mayo Clinic have evaluated the major sources of pain for some men during in-office prostate biopsy and an anesthetic method that can best lessen it.
read more
|
BPH & Male LUTS 
